Keyphrases
Aggressive Phenotype
16%
Anchorage-independent
8%
BON Cells
16%
BON-1
8%
Cell Cycle Arrest
8%
Cell Cycle Phases
8%
Cell Cycle Proteins
8%
Chk2
25%
Colony Formation
8%
Colony Growth
8%
Functional Biomarkers
8%
Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
8%
Immunohistochemistry
8%
In Vitro Assay
8%
L1 Loss
100%
Metastasis
16%
Metastatic Pancreatic Neuroendocrine Tumour
100%
Metastatic Potential
16%
Metastatic Tumor
8%
Negative Control
16%
Neuroendocrine Tumor Cell Lines
8%
Pancreatic Neuroendocrine Tumors (pNETs)
8%
Promoter Methylation
8%
Protein Array Analysis
8%
Proteomic Analysis
8%
QGP-1
8%
Re-expression
16%
Reverse Phase Protein Array
16%
RNA Sequencing (RNA-seq)
16%
Transcriptomics
8%
Translational Regulation
8%
UCHL1
100%
Western Blot
8%
Medicine and Dentistry
Anchorage
8%
Biological Marker
8%
Cell Cycle
100%
Cell Cycle Arrest
8%
Cell Cycle Checkpoint
8%
Cell Cycle Protein
8%
Cell Line
16%
Colony Formation
8%
G1 Phase
8%
Gastroenteropancreatic Neuroendocrine Tumor
8%
Immunohistochemistry
8%
In Vitro
16%
Metastasis Potential
16%
Metastatic Carcinoma
25%
Neuroendocrine Tumor Cell Line
8%
P21
16%
Pancreas Islet Cell Tumor
100%
Promoter Region
8%
Protein Microarray
16%
Protein Processing
8%
Proteomics
8%
RNA Sequence
16%
Sensitivity and Specificity
8%
Transcriptomics
8%
Ubiquitin Thiolesterase
100%
Upregulation
16%
Western Blot
8%
Biochemistry, Genetics and Molecular Biology
C-Terminus
100%
Cell Cycle
100%
Cell Cycle Arrest
8%
Cell Cycle Checkpoint
8%
Cell Cycle Protein
8%
Colony Formation
8%
G1 Phase
8%
Hydrolase
100%
P21
16%
Posttranslational Modification
8%
Promoter Region
8%
Protein Microarray
16%
Proteomics
8%
RNA Sequence
16%
Transcriptomics
8%
Ubiquitin
100%
Upregulation
16%
Western Blot
8%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
8%
Cell Cycle Protein
8%
Gastroenteropancreatic Neuroendocrine Tumor
8%
Metastasis Potential
16%
Pancreas Islet Cell Tumor
100%
RNA-Sequencing
16%
Ubiquitin Thiolesterase
100%
Western Blot
8%